Cytogenetic and molecular response with first- and second-generation tyrosine kinase inhibitor (TKI) therapy in simplicity: An observational study of patients with chronic-phase chronic myeloid Leukemia (CP-CML) Meeting Abstract


Authors: Cortes, J. E.; Chen, C.; Davis, C.; Goldberg, S. L.; Mauro, M. J.
Abstract Title: Cytogenetic and molecular response with first- and second-generation tyrosine kinase inhibitor (TKI) therapy in simplicity: An observational study of patients with chronic-phase chronic myeloid Leukemia (CP-CML)
Meeting Title: 61st Annual Meeting and Exposition of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 134
Issue: Suppl. 1
Meeting Dates: 2019 Dec 7-10
Meeting Location: Orlando, FL
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2019-11-13
Language: English
ACCESSION: WOS:000577160407054
DOI: 10.1182/blood-2019-127959
PROVIDER: wos
Notes: Meeting Abstract: 2929 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael John Mauro
    274 Mauro